<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Transplant</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Transplant</journal-id>
<journal-id journal-id-type="publisher-id">CLL</journal-id>
<journal-id journal-id-type="hwp">spcll</journal-id>
<journal-title-group>
<journal-title>Cell Transplantation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0963-6897</issn>
<issn pub-type="epub">1555-3892</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31161783</article-id>
<article-id pub-id-type="pmc">6767899</article-id>
<article-id pub-id-type="doi">10.1177/0963689718822811</article-id>
<article-id pub-id-type="publisher-id">10.1177_0963689718822811</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Analysis of Synapses in Cerebral Organoids</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yakoub</surname>
<given-names>Abraam M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0963689718822811">1</xref>
<xref ref-type="corresp" rid="corresp1-0963689718822811"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sadek</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="aff2-0963689718822811">2</xref>
<xref ref-type="aff" rid="aff3-0963689718822811">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0963689718822811">
<label>1</label>Department of Molecular and Cellular Physiology, Stanford University School
of Medicine, Stanford, CA, USA</aff>
<aff id="aff2-0963689718822811">
<label>2</label>Department of Pharmaceutical Biotechnology, University of Illinois College
of Pharmacy, Chicago, IL, USA</aff>
<aff id="aff3-0963689718822811">
<label>3</label>Department of Research and Development, Akorn Pharmaceuticals, Vernon Hills,
IL, USA</aff>
<author-notes>
<corresp id="corresp1-0963689718822811">Abraam M. Yakoub, Department of Molecular and
Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Email: <email>abraamyakoub@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>28</volume>
<issue>9-10</issue>
<fpage>1173</fpage>
<lpage>1182</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Inc, unless otherwise noted.
Manuscript content on this site is licensed under Creative Commons
Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits
non-commercial use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access pages
(<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Cerebral organoids are an emerging cutting-edge technology to model human brain
development and neurodevelopmental disorders, for which mouse models exhibit significant
limitations. In the human brain, synaptic connections define neural circuits, and synaptic
deficits account for various neurodevelopmental disorders. Thus, harnessing the full power
of cerebral organoids for human brain modeling requires the ability to visualize and
analyze synapses in cerebral organoids. Previously, we devised an optimized method to
generate human cerebral organoids, and showed that optimal organoids express mature-neuron
markers, including synaptic proteins and neurotransmitter receptors and transporters.
Here, we give evidence for synaptogenesis in cerebral organoids, via microscopical
visualization of synapses. We also describe multiple approaches to quantitatively analyze
synapses in cerebral organoids. Collectively, our work provides sufficient evidence for
the possibility of modeling synaptogenesis and synaptic disorders in cerebral organoids,
and may help advance the use of cerebral organoids in molecular neuroscience and studies
of neurodevelopmental disorders such as autism.</p>
</abstract>
<kwd-group>
<kwd>cerebral organoids</kwd>
<kwd>human brain</kwd>
<kwd>stem cells</kwd>
<kwd>synapses</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>autism</kwd>
<kwd>synaptic deficits</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September-October 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-0963689718822811" sec-type="intro">
<title>Introduction</title>
<p>Cerebral organoids are stem-cell derived, three-dimensional (3D) neural-tissue-like
structures, that recapitulate early (ca. first trimester) in vivo developing brain tissues.
While an in vitro system, cerebral organoids perhaps provide the only portal to studies of
human-specific brain development and disease in 3D. Cerebral organoids recapitulate
lamination and organization of the human cortex<sup><xref ref-type="bibr" rid="bibr1-0963689718822811">1</xref></sup>, diversity of the cell types observed in vivo (such as neuronal subtypes, glial
cells, and neuroepithelial and neuroprogenitor cells<sup><xref ref-type="bibr" rid="bibr2-0963689718822811">2</xref>,<xref ref-type="bibr" rid="bibr3-0963689718822811">3</xref></sup>), and even the gene expression profiles observed during human fetal neocortical
development as revealed by single-cell RNA-sequencing analyses<sup><xref ref-type="bibr" rid="bibr4-0963689718822811">4</xref></sup>. The organoid technology is still in its rather early stages, but the promise it
poses to the study of the human-specific developmental and disease neuroscience is enormous,
which has encouraged ongoing efforts to further improve the technology and reduce its
limitations, including attempts for circuitry reconstruction<sup><xref ref-type="bibr" rid="bibr5-0963689718822811">5</xref><xref ref-type="bibr" rid="bibr6-0963689718822811"></xref><xref ref-type="bibr" rid="bibr7-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr8-0963689718822811">8</xref></sup>, in order to enhance the organoids’ utility to study some aspects of human brain
development or developmental disorders.</p>
<p>Human cerebral organoids enabled detection of disease-relevant phenotypes and
characterization of disease mechanisms that could not be detected in traditional models<sup><xref ref-type="bibr" rid="bibr1-0963689718822811">1</xref>,<xref ref-type="bibr" rid="bibr9-0963689718822811">9</xref></sup>, including in vivo mouse models or the human two-dimensional model (stem-cell-derived
neurons). Some disease-associated gene mutations that are responsible for severe phenotypes
and devastating neurodevelopmental conditions in humans were found to exhibit no phenotype,
or a marginal, barely significant, phenotype in the mouse brain. For example, mouse models
for microcephaly-associated mutations (as in <italic>CDK5RAP2</italic> (CDK5
(cyclin-dependent kinase 5) related activator protein 2 or CDK5 regulatory
subunit-associated protein 2)) failed to show the severe microcephalic phenotype associated
with these mutations in human patients<sup><xref ref-type="bibr" rid="bibr1-0963689718822811">1</xref>,<xref ref-type="bibr" rid="bibr9-0963689718822811">9</xref>,<xref ref-type="bibr" rid="bibr10-0963689718822811">10</xref></sup>. Organoids were also used to investigate the pathological mechanisms of Zika virus
infection and its relationship to dysregulation of neurogenesis and neuroinflammatory
pathways and to microcephaly in humans<sup><xref ref-type="bibr" rid="bibr11-0963689718822811">11</xref><xref ref-type="bibr" rid="bibr12-0963689718822811"></xref><xref ref-type="bibr" rid="bibr13-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr14-0963689718822811">14</xref></sup>. Moreover, human forebrain organoids derived from induced pluripotent stem cells
(iPSCs) of patients carrying a mutation in <italic>Disrupted-in-schizophrenia 1</italic>
(<italic>DISC1</italic>), a gene associated with multiple neuropsychiatric disorders such
as schizophrenia, affective disorders and autism spectrum disorders (ASDs)<sup><xref ref-type="bibr" rid="bibr15-0963689718822811">15</xref>,<xref ref-type="bibr" rid="bibr16-0963689718822811">16</xref></sup>, revealed a role of this gene in cell cycle progression in radial glial cells and neurogenesis<sup><xref ref-type="bibr" rid="bibr17-0963689718822811">17</xref></sup>. Arguably, cerebral organoids were also reported to recapitulate a neurodegenerative
disease model. For example, cerebral organoids derived from a familial Alzheimer’s disease
(FAD) patient’s iPSCs showed aggregation of amyloid-β and hyperphosphorylated tau<sup><xref ref-type="bibr" rid="bibr18-0963689718822811">18</xref></sup>. Moreover, cerebral organoids harboring a frontotemporal dementia (FTD)-associated
tau mutation showed evidence of a CDK5-dependent tau phosphorylation and a decrease in
synaptophysin levels<sup><xref ref-type="bibr" rid="bibr19-0963689718822811">19</xref></sup>.</p>
<p>Thus far, cerebral organoids have mostly been used for studies that are focused on
functions of the radial glial and neural progenitor cells (including the aspects of
proliferation and neurogenesis) <sup><xref ref-type="bibr" rid="bibr13-0963689718822811">13</xref>,<xref ref-type="bibr" rid="bibr20-0963689718822811">20</xref><xref ref-type="bibr" rid="bibr21-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr22-0963689718822811">22</xref>,<xref ref-type="bibr" rid="bibr17-0963689718822811">17</xref></sup> or on non-synaptic aspects of neuronal biology such as neuronal differentiation,
neuronal migration, or gene expression and transcriptional pathways analyses<sup><xref ref-type="bibr" rid="bibr7-0963689718822811">7</xref>,<xref ref-type="bibr" rid="bibr8-0963689718822811">8</xref>,<xref ref-type="bibr" rid="bibr23-0963689718822811">23</xref></sup>. However, synaptic function is at the very center of neuronal functions and is
probably the most important neuronal function<sup><xref ref-type="bibr" rid="bibr24-0963689718822811">24</xref><xref ref-type="bibr" rid="bibr25-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr26-0963689718822811">26</xref></sup>. Moreover, analyzing synapses is essential to understanding the disease mechanisms of
neurodevelopmental disorders that are caused by deficits in synapses<sup><xref ref-type="bibr" rid="bibr27-0963689718822811">27</xref><xref ref-type="bibr" rid="bibr28-0963689718822811"></xref><xref ref-type="bibr" rid="bibr29-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr30-0963689718822811">30</xref></sup>. Despite its immense importance, thorough synapse analyses have not yet been
performed in cerebral organoids. Scarcely, some Ca<sup>2+</sup> imaging experiments and
electrophysiological analyses were performed on organoids<sup><xref ref-type="bibr" rid="bibr1-0963689718822811">1</xref>,<xref ref-type="bibr" rid="bibr5-0963689718822811">5</xref></sup>. While electrophysiological approaches, despite being highly tedious, provide
important insights into synaptic connectivity, synaptic microscopical analyses (such as
described here) complement the electrophysiological approaches by directly visualizing
synapses and determining synapse counts<sup><xref ref-type="bibr" rid="bibr31-0963689718822811">31</xref>,<xref ref-type="bibr" rid="bibr32-0963689718822811">32</xref></sup>.</p>
<p>Therefore, in this study, we attempted to visualize synaptogenesis in cerebral organoids,
via confocal microscopy. We have tested numerous approaches for analyzing synapses, and
concisely report here multiple assays that were shown to be compatible with cerebral
organoids. We provide ample procedural details and technical tips to allow researchers to
successfully reproduce these assays. Thus, we expect this study to help advance the field of
study of neurodevelopmental disorders and synaptogenesis in the human cerebral organoid
model.</p>
</sec>
<sec id="section2-0963689718822811" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-0963689718822811">
<title>Chemicals and Reagents</title>
<p>Materials used in generation of organoids were previously described in details<sup><xref ref-type="bibr" rid="bibr33-0963689718822811">33</xref></sup>. The following reagents were used for preparing the organoids for synapse analysis:
Tissue-Tek® O.C.T. Compound (Cat # 25608-930; Sakura, Alphen aan den Rijn, The
Netherlands), Tissue Path™ Disposable Base Molds (Cat # 22-363-553; Fisher Scientific,
Hampton, NH, USA), Goat serum (Cat # 16210064; Invitrogen, Carlsbad, CA, USA), Vectashield
4′,6-diamidino-2-phenylindole (DAPI) mounting medium (Cat # H-1200; Vector Labs,
Burlingame, CA, USA), Adhesive glass slides (Cat # I6172PLUS, Thermo Fisher, Waltham, MA,
USA), Coverslips (Cat # 102222; Thermo Fisher), Kimwipes (Cat # 06-666; Fisher
Scientific), and paraformaldehyde stock (32%) solution (Cat # 15714; Electron Microscopy
Sciences (EMS), Hatfield, PA, USA).</p>
<p>Paraformaldehyde solution for tissue fixation (4% paraformaldehyde solution, pH 7.4) can
be prepared by 1:8 dilution of the 32% stock solution in PBS pH 7.4; 4% paraformaldehyde
solution is to be stored in amber-colored or light-proof containers at 4°C for 1–2
weeks.</p>
<p>The following solutions were used: Blocking Solution (5–10% goat serum, 0.1% BSA, 0.3%
Triton X-100 in PBS), and Antibody Vehicle Solution (AVS) (1–2% goat serum, 0.1% Triton
X-100 in PBS).</p>
<sec id="section4-0963689718822811">
<title>Primary Antibodies</title>
<p>The following primary antibodies were used: Synapsin 1 (SYN1) antibody, rabbit
polyclonal antiserum (Cat # 106002; Synaptic Systems, Göttingen, Germany) was used at
the dilution of 1:1000. Microtubule-Associated Protein 2 (MAP2) antibody, chicken
polyclonal IgY (Cat # 188006; Synaptic Systems) was used at the dilution of 1:1000.
Glutamate NMDA Receptor Subunit 1 (GluNR1) antibody, mouse monoclonal IgG (Cat # 114011;
Synaptic Systems) was used at the dilution of 1:500. Vesicular Glutamate Transporter 1
(VGLUT1) antibody, Guinea pig polyclonal antiserum (Cat # AB5905; Millipore, Burlington,
MA, USA) was used at the dilution of 1:1000.</p>
</sec>
<sec id="section5-0963689718822811">
<title>Secondary Antibodies</title>
<p>Secondary antibodies conjugated with Alexa Fluor-488, -546 or -633 (Molecular Probes,
Invitrogen) were used for confocal microscopy, as follows: Goat anti-rabbit IgG
secondary antibody—Alexa Fluor-488 (Cat # A-11008; Invitrogen); Goat anti-mouse IgG
secondary antibody—Alexa Fluor-546 (Cat # A-11030; Invitrogen); Goat anti-chicken IgY
secondary antibody—Alexa Fluor-546 (Cat # A-11040; Invitrogen); Goat anti-Guinea pig IgG
secondary antibody—Alexa Fluor-633 (Cat # A-21105; Invitrogen). Secondary antibodies
were generally used at the dilution of 1:1000, except the anti-Guinea pig—Alexa
Fluor-633 secondary antibodies, which were used at the dilution of 1:500.</p>
</sec>
</sec>
<sec id="section6-0963689718822811">
<title>Equipment</title>
<p>The following equipment was used: Liquid nitrogen tank and liquid nitrogen bucket,
ImmEdge™ Hydrophobic Barrier Pen (Cat # 101098-065; VWR, Radnor, PA, USA),
temperature-controlled microtome cryostat (Leica Research Cryostat, Cat # CM3050 S; Leica
Biosystems, Buffalo Grove, IL, USA), Confocal microscope (Nikon, or Zeiss),
NIS-Elements<sup>TM</sup> software (Nikon, Tokyo, Japan) and sterile forceps.</p>
</sec>
<sec id="section7-0963689718822811">
<title>Generation and Microscopy of Cerebral Organoids</title>
<p>Generation of the human cerebral organoids was performed as summarized in <xref ref-type="fig" rid="fig1-0963689718822811">Fig 1</xref>. Briefly, human cerebral
organoids were generated from human embryonic stem cells (ESCs), (H1 or WA-01 cell line)
in a stepwise procedure that encompasses five stages: (1) induction of embryoid bodies by
seeding the ESCs dispersed in Medium I (contains Knockout serum replacement and basic
fibroblast growth factor (bFGF)) on a low-attachment surface for 6–7 days; (2) induction
of neuroectoderm for 4–5 days in the presence of Medium II (contains N2-supplement and
heparin); (3) embedding the developing organoid in a drop of matrigel and growing it in a
stationary culture containing Medium III (contains Neurobasal Medium and B27-supplement)
for 4–5 days; (4) transferring the developing organoids to shaking cultures containing
Medium IV (contains Neurobasal Medium, B27-supplement and retinoic acid); and (5) if
desired, additional “maturating factors” (e.g. ascorbic acid, cyclic adenosine
monophosphate (cAMP), brain-derived neurotropic factor (BDNF), glial cell line-derived
neurotropic factor (GDNF), and transforming growth factor-β (TGFβ)) may be added to the
organoids from day 60 post-induction of the embryoid bodies. Neuron-rich organoids can be
observed within 40–50 days from the initial induction of embryoid bodies. Optimal
organoids at the age of ∼75 days reach a diameter of ∼3–5 mm. Mature neurons could be
reached by day 75–90 from the initial induction. Detailed composition of the various
reagents was described previously<sup><xref ref-type="bibr" rid="bibr33-0963689718822811">33</xref></sup>. Organoids analyzed in this study were used on day 80 post-induction. Three
independent batches of organoids were analyzed; in each batch, 10–20 organoids were
analyzed. From each organoid ∼10 sections were arbitrarily selected for staining and
confocal microscopy.</p>
<fig id="fig1-0963689718822811" orientation="portrait" position="float">
<label>Fig 1.</label>
<caption>
<p>Overview of the cerebral organoid development procedure. Human ESCs were induced into
cerebral organoids using the indicated multi-step procedure, where different media and
treatments were introduced at each stage of the protocol. Timeline and approximate
size measurements at each stage are also indicated.</p>
</caption>
<graphic xlink:href="10.1177_0963689718822811-fig1"></graphic>
</fig>
<p>To prepare the organoids for microscopy and synapse imaging, place the organoid in a
sterile Petri dish. With the help of a surgical microscope, use a blunt tool such as
blunt-end forceps or a 1000 μl pipette tip to carefully unwrap the organoid from the
matrigel coat. Discard the matrigel wrap. Work carefully and quickly to avoid damaging the
organoid structure. Immerse the matrigel-freed organoid in OCT Compound<sup>TM</sup> in
Tissue Path Disposable Base Molds. Make sure that there is a layer of OCT
Compound<sup>TM</sup> below and above the organoid (i.e. the organoid should be
completely surrounded by OCT Compound<sup>TM</sup> from all directions). If the organoid
sinks down to the bottom of the mold, center it to the middle of the OCT
Compound<sup>TM</sup> using a blunt pipette tip gently. Snap-freeze the OCT
Compound<sup>TM</sup>-immersed organoid using liquid nitrogen (preferably) or
ethanol-dry ice mix. Liquid nitrogen snap-frozen organoids can be stored for long periods
of time (6–12 months, or longer) at –80°C.</p>
<p>Before sectioning the organoids, transfer the frozen organoids from –80°C to –20°C for at
least 2 h or preferably overnight. We observed that gradually cooling and stabilizing the
organoid at –20°C (which is the temperature for cryosectioning) gives better-quality
sections that adhere to the slide better. Using a suitable cryostat at approximately –20°C
(sometimes we found that –16°C to –17°C temperature may produce better quality sections
than slightly lower temperatures), cut organoid sections at the desirable thickness. We
found that a section thickness between 8 μm and 15 μm is ideal for on-slide staining and
confocal microscopy. Collect the cryostat-cut sections on SuperfrostPlus<sup>TM</sup>
glass slides. The tissue should adhere to the slide; if not, finely adjust the cryostat
temperature as noted above, which we found helped reduce this problem. Air-dry the
sections at room temperature for ∼15–20 min. Using a barrier pen, draw a line (hydrophobic
barrier) around each section, to help save expensive reagents (such as antibodies) and
reduce expenses.</p>
<p>Fix the sections on the slide using a suitable fixative. Testing various fixatives and
fixation durations, we found that cold 4% PFA for 8–12 min is optimal. Remove the fixative
solution off the section using a pipette, and add ∼100 μl PBS on the tissue. Perform this
wash process twice, for 5 min each time, at room temperature. Block non-specific binding
for 1 h at room temperature, by adding ∼100 μl (enough volume to cover the tissue) of
Blocking Solution to the section. Incubate the sections with primary antibody (diluted in
AVS) overnight at 4°C on a rotating shaker. Optimizing antibody dilution and exposure
duration may be performed for the different antibodies. Wash the primary antibody off the
sections, with PBS, two to three times, each for 5–20 min (the number of washes and the
wash duration may be optimized for each antibody). Incubate the sections with
fluorophore-conjugated secondary antibody diluted in AVS for 45–60 min at room temperature
in the dark. Remove the secondary antibody off the sections and wash with PBS for three to
four times, each for 15 min (numbers and duration of washes may be optimized depending on
the secondary antibody to be used). Carefully remove any remaining moisture on the slide
using Kimwipes without touching the sections. Mount the sections in DAPI-containing
mounting medium, and cover the slide with the coverslip being cautious to not introduce
air bubbles under the coverslip. Proceed to imaging using a suitable confocal microscope
with a 100x (or at least 63x) magnification lens for best visualization of synapses, as
performed here. Slides can be stored at room temperature in light-proof containers.</p>
</sec>
</sec>
<sec id="section8-0963689718822811" sec-type="results">
<title>Results</title>
<sec id="section9-0963689718822811">
<title>Synapse Analysis Using Single Staining for SYN1 or GluNR1</title>
<p>Organoid sections can be stained for SYN1 or GluNR1, via the procedure described above
and using primary antibodies against SYN1 or GluNR1, and secondary antibodies conjugated
with a suitable fluorophore, such as Alexa Fluor-488. Punctate SYN1 or GluNR1 staining
denotes synapses, as shown in <xref ref-type="fig" rid="fig2-0963689718822811">Fig
2</xref>.</p>
<fig id="fig2-0963689718822811" orientation="portrait" position="float">
<label>Fig 2.</label>
<caption>
<p>Synapse analysis using single staining for SYN1 or GluNR1. A. Organoid sections were
stained for SYN1 (green) and nuclei (DAPI, blue), and imaged using confocal
microscopy; scale bar 10 μm. B. Organoid sections were stained for GluNR1 (green) and
nuclei (DAPI, blue) and imaged using confocal microscopy; scale bar 60 μm.</p>
</caption>
<graphic xlink:href="10.1177_0963689718822811-fig2"></graphic>
</fig>
</sec>
<sec id="section10-0963689718822811">
<title>Synapse Analysis Using SYN1 and MAP2 Double Staining</title>
<p>Organoid sections can be stained for MAP2 (stains neuronal dendrites) and SYN1 (stains
synapses) via the procedure above, using primary antibodies against SYN1 and MAP2, and
secondary antibodies conjugated with Alexa Fluor-488 (SYN1, green) and -546 (MAP2, red).
Synapses can be observed as SYN1+ punctae that colocalize with MAP2 (<xref ref-type="fig" rid="fig3-0963689718822811">Fig 3</xref>).</p>
<fig id="fig3-0963689718822811" orientation="portrait" position="float">
<label>Fig 3.</label>
<caption>
<p>Synapse analysis using double staining for SYN1 and MAP2. A, B. Various organoid
sections stained for SYN1 (green), MAP2 (red), and nuclei (DAPI, blue); scale bar 10
μm. C. An organoid section stained for SYN1 and MAP2 (scale bar 10 μm); right panel
shows a higher magnification of the box-enclosed area in the middle panel (scale bar 2
μm).</p>
</caption>
<graphic xlink:href="10.1177_0963689718822811-fig3"></graphic>
</fig>
</sec>
<sec id="section11-0963689718822811">
<title>Synapse Analysis Using SYN1 and PSD95 Double Staining</title>
<p>SYN1 is a presynaptic adaptor protein, while PSD95 is a postsynaptic adaptor present on
the excitatory postsynapses. Thus, synapses appear as punctae that are double-positive for
both SYN1 and PSD95. The organoid sections can be stained for SYN1 and PSD95 via the
procedure above, using primary antibodies against SYN1 and PSD95, and Alexa Fluor-488- or
-546-conjugated secondary antibodies. <xref ref-type="fig" rid="fig4-0963689718822811">Fig
4A</xref> shows synapses in organoid sections that stain for both SYN1 and PSD95.
Analysis of synaptic punctae should yield a Fluorescence-Relative distance curve, similar
to that shown in <xref ref-type="fig" rid="fig4-0963689718822811">Fig 4B</xref>, where the
puncta shows that the presynapse and the postsynapse are spatially proximal yet separated,
with SYN1 occupying the presynaptic localization and PSD95 occupying the postsynaptic
localization. We analyzed a large number of synapses (∼100 synapses) throughout the
section, and show a representative example in <xref ref-type="fig" rid="fig4-0963689718822811">Fig 4B</xref>. This analysis can be performed using
automated microscopy software (NIS-Elements; Nikon), which measures the distance of each
fluorophore in a selected puncta relative to a reference point. The analysis confirms the
spatial separation of the pre- and post-synaptic markers in the puncta; a bona-fide
synapse should show that the presynaptic and the postsynaptic markers are spatially
separated (relative distance &gt; 0) and not superimposable (relative distance = 0).</p>
<fig id="fig4-0963689718822811" orientation="portrait" position="float">
<label>Fig 4.</label>
<caption>
<p>Synapse analysis using double staining for SYN1 and PSD95. A. An organoid section was
stained for SYN1 (red), PSD95 (green), and nuclei (DAPI, blue); scale bar 10 μm. B.
Fluorescence–Relative distance analysis for two random Syn1+/PSD95+ punctae in (A),
showing the spatial separation of SYN1 and PSD95 peaks, denoting their presynaptic and
postsynaptic localizations, respectively. Puncta analysis was performed using Nikon’s
NIS-Elements<sup>TM</sup> software.</p>
</caption>
<graphic xlink:href="10.1177_0963689718822811-fig4"></graphic>
</fig>
</sec>
<sec id="section12-0963689718822811">
<title>Synapse Analysis Using SYN1 and GluNR1 Double Staining</title>
<p>While SYN1 is a presynaptic marker, GluNR1 is a postsynaptic glutamate (NMDA) receptor on
excitatory synapses. Thus, synapses appear as punctae double positive for both SYN1 and
GluNR1. Organoid sections can be stained as usual, using primary antibodies against SYN1
and GluNR1, and Alexa Fluor-488 or -546-conjugated secondary antibodies. Synapses can be
observed as SYN1+/GluNR1+ punctae as shown in <xref ref-type="fig" rid="fig5-0963689718822811">Fig 5A</xref>.</p>
<fig id="fig5-0963689718822811" orientation="portrait" position="float">
<label>Fig 5.</label>
<caption>
<p>Synapse analysis using double and triple staining for SYN1, GluNR1, and VGLUT1. A. An
organoid section stained for SYN1 (green), GluNR1 (red), and nuclei (DAPI, blue);
scale bar 50 μm. B. An organoid section stained for SYN1 (green), GluNR1 (red), VGLUT1
(purple), and nuclei (DAPI, blue); scale bar 50 μm (left panel) or 10 μm (right
panel). C. Fluorescence–Relative distance curves for two arbitrarily chosen
SYN1+/VGLUT1+/GluNR1+ punctae in (B), showing spatial separation of SYN1, or VGLUT1,
and GluNR1, and indicating the presynaptic localization of SYN1 or VGLUT1 and the
postsynaptic localization of GluNR1. Analysis of the punctae was performed using
Nikon’s NIS-Elements<sup>TM</sup> software.</p>
</caption>
<graphic xlink:href="10.1177_0963689718822811-fig5"></graphic>
</fig>
</sec>
<sec id="section13-0963689718822811">
<title>Synapse Analysis Using SYN1, VGLUT1 and GluNR1 Triple Staining</title>
<p>Synapses could be visualized using triple staining for SYN1, GluNR1 along with VGLUT1, a
glutamate transporter present on the presynapse. Follow the staining Protocol above, using
primary antibodies against SYN1, VGLUT1 and GluNR1, and Alexa Fluor-488, -546, and
-633-conjugated secondary antibodies. Thus, synapses appear as punctae that are double and
triple positive for SYN1, VGLUT1, and GluNR1, as shown in <xref ref-type="fig" rid="fig5-0963689718822811">Fig 5B</xref>. Analysis of any synaptic puncta should yield
a Fluorescence-Relative distance curve, similar to that shown in <xref ref-type="fig" rid="fig5-0963689718822811">Fig 5C</xref>, where the punctae show that the presynapse
and the postsynapse are spatially proximal but separated, with SYN1 and VGLUT1 localized
presynaptically and GluNR1 localized postsynaptically.</p>
</sec>
</sec>
<sec id="section14-0963689718822811" sec-type="discussion">
<title>Discussion</title>
<p>Synaptic function mediates circuitry development in the brain and regulates animal
behavior. Deficits in circuitry development underlie devastating neurodevelopmental
conditions, such as ASD, intellectual, communication and learning disorders,
attention-deficit/hyperactivity disorder (ADHD), and other conditions. Harnessing the power
of the organoid model to understand the mechanisms of these conditions requires the ability
to analyze synapses in such a promising model. Here, we have described simple,
immunofluorescence-based methods that we have tested and optimized to visualize and analyze
synapses in sections of human cerebral organoids.</p>
<p>Synapses’ proteomic composition is very complex, comprising hundreds of proteins and
protein isoforms<sup><xref ref-type="bibr" rid="bibr34-0963689718822811">34</xref>,<xref ref-type="bibr" rid="bibr35-0963689718822811">35</xref></sup>, and varies significantly between synapse subtypes<sup><xref ref-type="bibr" rid="bibr35-0963689718822811">35</xref><xref ref-type="bibr" rid="bibr36-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr37-0963689718822811">37</xref></sup>, and thus synapse analysis is not a simple task. Previous studies on the mouse cortex
have attempted to label synapses using various presynaptic proteins that are common to all
synapse subtypes as synaptic markers, such as synaptophysin, bassoon, and SYN1, but only
SYN1, a phosphoprotein that is largely concentrated at the presynaptic boutons<sup><xref ref-type="bibr" rid="bibr38-0963689718822811">38</xref>,<xref ref-type="bibr" rid="bibr39-0963689718822811">39</xref></sup>, showed the most robust labeling, characterized by clearly visible punctae with very
little nonspecific (non-synaptic) labeling<sup><xref ref-type="bibr" rid="bibr40-0963689718822811">40</xref></sup>. Quite intriguingly, comparing the results of electron microscopy (EM) and
immunofluorescence analyses in parallel has shown that the vast majority of synapses
confirmed by EM stained positively for SYN1, further stressing the reliability of SYN1
immunofluorescence labeling for assaying synapses<sup><xref ref-type="bibr" rid="bibr40-0963689718822811">40</xref></sup>. Learning from all those studies, we have devised here the confocal microscopical
synapse analyses described, using SYN1 staining. SYN1 staining yields a non-cell-body
punctate staining pattern characteristic of synapses<sup><xref ref-type="bibr" rid="bibr24-0963689718822811">24</xref>,<xref ref-type="bibr" rid="bibr40-0963689718822811">40</xref></sup>.</p>
<p>In addition to SYN1 on the presynapse, glutamate receptors decorate the excitatory postsyanpses<sup><xref ref-type="bibr" rid="bibr34-0963689718822811">34</xref><xref ref-type="bibr" rid="bibr35-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr36-0963689718822811">36</xref></sup>. Glutamate NMDA receptors are of cardinal importance for mediating Ca<sup><xref ref-type="bibr" rid="bibr2-0963689718822811">2</xref>+</sup>-dependent postsynaptic
processes associated with long-term potentiation and depression and learning and memory<sup><xref ref-type="bibr" rid="bibr41-0963689718822811">41</xref>,<xref ref-type="bibr" rid="bibr42-0963689718822811">42</xref></sup>. Although presynaptic or extrasynaptic presence of NMDA receptors was suggested by
some reports<sup><xref ref-type="bibr" rid="bibr43-0963689718822811">43</xref></sup>, presynaptic or extrasynaptic expression of NMDA receptors was shown to be confined
to a small subset of neurons in the mouse brain and mostly for the 2B subunit of the
receptor (GluN2B)<sup><xref ref-type="bibr" rid="bibr44-0963689718822811">44</xref><xref ref-type="bibr" rid="bibr45-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr46-0963689718822811">46</xref></sup>. The overwhelming majority, however, of NMDA receptors are expressed at the
excitatory postsynapses and have been used in the field as a reliable postsynaptic marker in
mouse brain sections or neuron culture<sup><xref ref-type="bibr" rid="bibr47-0963689718822811">47</xref><xref ref-type="bibr" rid="bibr48-0963689718822811"></xref><xref ref-type="bibr" rid="bibr49-0963689718822811"></xref><xref ref-type="bibr" rid="bibr50-0963689718822811"></xref><xref ref-type="bibr" rid="bibr51-0963689718822811"></xref><xref ref-type="bibr" rid="bibr52-0963689718822811"></xref><xref ref-type="bibr" rid="bibr53-0963689718822811"></xref><xref ref-type="bibr" rid="bibr54-0963689718822811"></xref><xref ref-type="bibr" rid="bibr55-0963689718822811"></xref><xref ref-type="bibr" rid="bibr56-0963689718822811"></xref><xref ref-type="bibr" rid="bibr57-0963689718822811"></xref><xref ref-type="bibr" rid="bibr58-0963689718822811"></xref>–<xref ref-type="bibr" rid="bibr59-0963689718822811">59</xref></sup>. While multiple NMDA receptor subtypes exist, GluNR1 is the most important subunit as
it is required for activity and is expressed mostly postsynaptically<sup><xref ref-type="bibr" rid="bibr60-0963689718822811">60</xref></sup>, which subunit we have used in our assays here. GluNR1 staining in organoid sections
yielded a punctate staining pattern as expected for synapses. Moreover, the spatial analysis
of the SYN1/VGLUT1/GluNR1 synaptic punctae in Fig <xref ref-type="fig" rid="fig5-0963689718822811">5C</xref> clearly shows GluNR1’s postsynaptic localization and
distance from the presynaptic proteins (SYN1 or VGLUT1); notice that SYN1 and VGLUT1 peaks
are spatially superimposable or very close to one another, whereas the GluNR1 peak is
significantly farther (denoting postsynaptic localization).</p>
<p>Furthermore, to add more confidence to SYN1 or GluNR1 single-staining-based
immunofluorescence visualization of synapses, we have devised double and triple labeling
involving SYN1 along with another presynaptic marker such as VGLUT1, or postsynaptic markers
such as PSD95 and GluNR1. Colocalization of the presynaptic marker with the postsynaptic
marker and the Fluorescence-Relative distance curves of those synapses collectively confirm
the synaptic nature of the immunopositive punctae visualized microscopically.</p>
<p>Traditionally, besides immunofluorescence, synapses have been analyzed using EM. EM is
probably the most accurate assay of visualizing synapses; however, EM approaches may have
some limitations, such as being a low-throughput method, limiting the possibility of using
it to compare a large number of experimental conditions<sup><xref ref-type="bibr" rid="bibr61-0963689718822811">61</xref>,<xref ref-type="bibr" rid="bibr62-0963689718822811">62</xref></sup>. We believe that the immunofluorescence- and confocal microscopy-based approaches
described here will complement other approaches to visualize synapses in organoids
representing multiple genetic or pharmacological conditions, and the conditions that seem
promising via this immunofluorescence microscopical approach could be further validated and
analyzed for synaptic connectivity and neurotransmitter release via electrophysiological approaches<sup><xref ref-type="bibr" rid="bibr31-0963689718822811">31</xref>,<xref ref-type="bibr" rid="bibr32-0963689718822811">32</xref></sup>. Overall, the work described here will enhance the utility of the human cerebral
organoid model in studies of circuitry and molecular neuroscience and to investigate
synaptic deficits that account for certain neurodevelopmental disorders.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0963689718822811">
<p><bold>Ethical Approval:</bold> Ethical approval is not applicable to this article.</p>
</fn>
<fn fn-type="other" id="fn2-0963689718822811">
<p><bold>Statement of Human and Animal Rights:</bold> This article does not contain any studies with human or animal subjects.</p>
</fn>
<fn fn-type="other" id="fn3-0963689718822811">
<p><bold>Statement of Informed Consent:</bold> This article involves no human subjects; and informed consent is not applicable.</p>
</fn>
<fn fn-type="COI-statement" id="fn4-0963689718822811">
<p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research,
authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn5-0963689718822811">
<p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or
publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0963689718822811">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Bicknell</surname><given-names>LS</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Homfray</surname><given-names>T</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>AP</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group>
<article-title>Cerebral organoids model human brain development and
microcephaly</article-title>. <source/>Nature.
<year>2013</year>;<volume>501</volume>(<issue>7467</issue>):<fpage>373</fpage>–<lpage>379</lpage>.<pub-id pub-id-type="pmid">23995685</pub-id></mixed-citation>
</ref>
<ref id="bibr2-0963689718822811">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quadrato</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Macosko</surname><given-names>EZ</given-names></name><name><surname>Sherwood</surname><given-names>JL</given-names></name><name><surname>Min Yang</surname><given-names>S</given-names></name><name><surname>Berger</surname><given-names>DR</given-names></name><name><surname>Maria</surname><given-names>N</given-names></name><name><surname>Scholvin</surname><given-names>J</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Kinney</surname><given-names>JP</given-names></name><name><surname>Boyden</surname><given-names>ES</given-names></name><name><surname>Lichtman</surname><given-names>JW</given-names></name><name><surname>Williams</surname><given-names>ZM</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group>
<article-title>Cell diversity and network dynamics in photosensitive
human brain organoids</article-title>. <source/>Nature.
<year>2017</year>;<volume>545</volume>(<issue>7652</issue>):<fpage>48</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">28445462</pub-id></mixed-citation>
</ref>
<ref id="bibr3-0963689718822811">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jo</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>AX</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Midbrain-like organoids from human pluripotent stem cells contain
functional dopaminergic and neuromelanin-producing neurons</article-title>. <source/>Cell
Stem Cell.
<year>2016</year>;<volume>19</volume>(<issue>2</issue>):<fpage>248</fpage>–<lpage>257</lpage>.<pub-id pub-id-type="pmid">27476966</pub-id></mixed-citation>
</ref>
<ref id="bibr4-0963689718822811">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Badsha</surname><given-names>F</given-names></name><name><surname>Florio</surname><given-names>M</given-names></name><name><surname>Kanton</surname><given-names>S</given-names></name><name><surname>Gerber</surname><given-names>T</given-names></name><name><surname>Wilsch-Bräuninger</surname><given-names>M</given-names></name><name><surname>Lewitus</surname><given-names>E</given-names></name><name><surname>Sykes</surname><given-names>A</given-names></name><name><surname>Hevers</surname><given-names>W</given-names></name><name><surname>Lancaster</surname><given-names>M</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Human cerebral organoids recapitulate gene expression programs of fetal
neocortex development</article-title>. <source/>Proc Natl Acad Sci U S A.
<year>2015</year>;<volume>112</volume>(<issue>51</issue>):<fpage>15672</fpage>–<lpage>15677</lpage>.<pub-id pub-id-type="pmid">26644564</pub-id></mixed-citation>
</ref>
<ref id="bibr5-0963689718822811">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Song</surname><given-names>MM</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Brain-region-specific organoids using mini-bioreactors for modeling ZIKV
exposure</article-title>. <source/>Cell.
<year>2016</year>;<volume>165</volume>(<issue>5</issue>):<fpage>1238</fpage>–<lpage>1254</lpage>.<pub-id pub-id-type="pmid">27118425</pub-id></mixed-citation>
</ref>
<ref id="bibr6-0963689718822811">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Corsini</surname><given-names>NS</given-names></name><name><surname>Wolfinger</surname><given-names>S</given-names></name><name><surname>Gustafson</surname><given-names>EH</given-names></name><name><surname>Phillips</surname><given-names>AW</given-names></name><name><surname>Burkard</surname><given-names>TR</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Livesey</surname><given-names>FJ</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group>
<article-title>Guided self-organization and cortical plate formation in
human brain organoids</article-title>. <source/>Nat Biotechnol.
<year>2017</year>;<volume>35</volume>(<issue>7</issue>):<fpage>659</fpage>–<lpage>666</lpage>.<pub-id pub-id-type="pmid">28562594</pub-id></mixed-citation>
</ref>
<ref id="bibr7-0963689718822811">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Birey</surname><given-names>F</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Makinson</surname><given-names>CD</given-names></name><name><surname>Islam</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Huber</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>HC</given-names></name><name><surname>Metzler</surname><given-names>KRC</given-names></name><name><surname>Panagiotakos</surname><given-names>G</given-names></name><name><surname>Thom</surname><given-names>N</given-names></name><name><surname>O’Rourke</surname><given-names>NA</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name><name><surname>Bernstein</surname><given-names>JA</given-names></name><name><surname>Hallmayer</surname><given-names>J</given-names></name><name><surname>Huguenard</surname><given-names>JR</given-names></name><name><surname>Paşca</surname><given-names>SP</given-names></name></person-group>
<article-title>Assembly of functionally integrated human forebrain
spheroids</article-title>. <source/>Nature.
<year>2017</year>;<volume>545</volume>(<issue>7652</issue>):<fpage>54</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">28445465</pub-id></mixed-citation>
</ref>
<ref id="bibr8-0963689718822811">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagley</surname><given-names>JA</given-names></name><name><surname>Reumann</surname><given-names>D</given-names></name><name><surname>Bian</surname><given-names>S</given-names></name><name><surname>Lévi-Strauss</surname><given-names>J</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group>
<article-title>Fused cerebral organoids model interactions between brain
regions</article-title>. <source/>Nat Methods.
<year>2017</year>;<volume>14</volume>(<issue>7</issue>):<fpage>743</fpage>–<lpage>751</lpage>.<pub-id pub-id-type="pmid">28504681</pub-id></mixed-citation>
</ref>
<ref id="bibr9-0963689718822811">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrera</surname><given-names>JA</given-names></name><name><surname>Kao</surname><given-names>LR</given-names></name><name><surname>Hammer</surname><given-names>RE</given-names></name><name><surname>Seemann</surname><given-names>J</given-names></name><name><surname>Fuchs</surname><given-names>JL</given-names></name><name><surname>Megraw</surname><given-names>TL</given-names></name></person-group>
<article-title>CDK5RAP2 regulates centriole engagement and cohesion in
mice</article-title>. <source/>Dev Cell.
<year>2010</year>;<volume>18</volume>:<fpage>913</fpage>–<lpage>926</lpage>.<pub-id pub-id-type="pmid">20627074</pub-id></mixed-citation>
</ref>
<ref id="bibr10-0963689718822811">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hattori</surname><given-names>N</given-names></name></person-group>
<article-title>Cerebral organoids model human brain development and
microcephaly</article-title>. <source/>Mov Disord.
<year>2014</year>;<volume>29</volume>(<issue>2</issue>):<fpage>185</fpage>.<pub-id pub-id-type="pmid">24375826</pub-id></mixed-citation>
</ref>
<ref id="bibr11-0963689718822811">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcez</surname><given-names>PP</given-names></name><name><surname>Loiola</surname><given-names>EC</given-names></name><name><surname>Madeiro da Costa</surname><given-names>R</given-names></name><name><surname>Higa</surname><given-names>LM</given-names></name><name><surname>Trindade</surname><given-names>P</given-names></name><name><surname>Delvecchio</surname><given-names>R</given-names></name><name><surname>Nascimento</surname><given-names>JM</given-names></name><name><surname>Brindeiro</surname><given-names>R</given-names></name><name><surname>Tanuri</surname><given-names>A</given-names></name><name><surname>Rehen</surname><given-names>SK</given-names></name></person-group>
<article-title>Zika virus impairs growth in human neurospheres and brain
organoids</article-title>. <source/>Science.
<year>2016</year>;<volume>352</volume>(<issue>6287</issue>):<fpage>816</fpage>–<lpage>818</lpage>.<pub-id pub-id-type="pmid">27064148</pub-id></mixed-citation>
</ref>
<ref id="bibr12-0963689718822811">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dang</surname><given-names>J</given-names></name><name><surname>Tiwari</surname><given-names>SK</given-names></name><name><surname>Lichinchi</surname><given-names>G</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Patil</surname><given-names>VS</given-names></name><name><surname>Eroshkin</surname><given-names>AM</given-names></name><name><surname>Rana</surname><given-names>TM</given-names></name></person-group>
<article-title>Zika virus depletes neural progenitors in human cerebral
organoids through activation of the innate immune receptor TLR3</article-title>.
<source/>Cell Stem Cell.
<year>2016</year>;<volume>19</volume>(<issue>2</issue>):<fpage>258</fpage>–<lpage>265</lpage>.<pub-id pub-id-type="pmid">27162029</pub-id></mixed-citation>
</ref>
<ref id="bibr13-0963689718822811">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>E</given-names></name><name><surname>Ramani</surname><given-names>A</given-names></name><name><surname>Karow</surname><given-names>U</given-names></name><name><surname>Gottardo</surname><given-names>M</given-names></name><name><surname>Natarajan</surname><given-names>K</given-names></name><name><surname>Gooi</surname><given-names>LM</given-names></name><name><surname>Goranci-Buzhala</surname><given-names>G</given-names></name><name><surname>Krut</surname><given-names>O</given-names></name><name><surname>Peters</surname><given-names>F</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><name><surname>Kuivanen</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Recent zika virus isolates induce premature differentiation of neural
progenitors in human brain organoids</article-title>. <source/>Cell Stem Cell.
<year>2017</year>;<volume>20</volume>(<issue>3</issue>):<fpage>397</fpage>–<lpage>406</lpage>.e5.<pub-id pub-id-type="pmid">28132835</pub-id></mixed-citation>
</ref>
<ref id="bibr14-0963689718822811">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wells</surname><given-names>MF</given-names></name><name><surname>Salick</surname><given-names>MR</given-names></name><name><surname>Wiskow</surname><given-names>O</given-names></name><name><surname>Ho</surname><given-names>DJ</given-names></name><name><surname>Worringer</surname><given-names>KA</given-names></name><name><surname>Ihry</surname><given-names>RJ</given-names></name><name><surname>Kommineni</surname><given-names>S</given-names></name><name><surname>Bilican</surname><given-names>B</given-names></name><name><surname>Klim</surname><given-names>JR</given-names></name><name><surname>Hill</surname><given-names>EJ</given-names></name><name><surname>Kane</surname><given-names>LT</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Genetic ablation of AXL does not protect human neural progenitor cells and
cerebral organoids from zika virus infection</article-title>. <source/>Cell Stem
Cell.
<year>2016</year>;<volume>19</volume>(<issue>6</issue>):<fpage>703</fpage>–<lpage>708</lpage>.<pub-id pub-id-type="pmid">27912091</pub-id></mixed-citation>
</ref>
<ref id="bibr15-0963689718822811">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blackwood</surname><given-names>DH</given-names></name><name><surname>Fordyce</surname><given-names>A</given-names></name><name><surname>Walker</surname><given-names>MT</given-names></name><name><surname>St Clair</surname><given-names>DM</given-names></name><name><surname>Porteous</surname><given-names>DJ</given-names></name><name><surname>Muir</surname><given-names>WJ</given-names></name></person-group>
<article-title>Schizophrenia and affective disorders–cosegregation with a
translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical
and P300 findings in a family</article-title>. <source/>Am J Hum Genet.
<year>2001</year>;<volume>69</volume>(<issue>2</issue>):<fpage>428</fpage>–<lpage>433</lpage>.<pub-id pub-id-type="pmid">11443544</pub-id></mixed-citation>
</ref>
<ref id="bibr16-0963689718822811">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomson</surname><given-names>PA</given-names></name><name><surname>Malavasi</surname><given-names>EL</given-names></name><name><surname>Grunewald</surname><given-names>E</given-names></name><name><surname>Soares</surname><given-names>DC</given-names></name><name><surname>Borkowska</surname><given-names>M</given-names></name><name><surname>Millar</surname><given-names>JK</given-names></name></person-group>
<article-title>DISC1 genetics, biology and psychiatric
illness</article-title>. <source/>Front Biol.
<year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>31</lpage>.</mixed-citation>
</ref>
<ref id="bibr17-0963689718822811">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Kang</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Jacob</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Mao</surname><given-names>M</given-names></name><name><surname>Poon</surname><given-names>RYC</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name></person-group>, <etal>et al.</etal>
<article-title>DISC1 regulates neurogenesis via modulating kinetochore attachment of
Ndel1/Nde1 during mitosis</article-title>. <source/>Neuron.
<year>2017</year>;<volume>96</volume>(<issue>5</issue>):<fpage>1041</fpage>–<lpage>1054</lpage>.<pub-id pub-id-type="pmid">29103808</pub-id></mixed-citation>
</ref>
<ref id="bibr18-0963689718822811">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raja</surname><given-names>WK</given-names></name><name><surname>Mungenast</surname><given-names>AE</given-names></name><name><surname>Lin</surname><given-names>YT</given-names></name><name><surname>Ko</surname><given-names>T</given-names></name><name><surname>Abdurrob</surname><given-names>F</given-names></name><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name></person-group>
<article-title>Self-organizing 3D human neural tissue derived from
induced pluripotent stem cells recapitulate Alzheimer’s disease
phenotypes</article-title>. <source/>Plos One.
<year>2016</year>;<volume>11</volume>(<issue>9</issue>):<fpage>e0161969</fpage>.<pub-id pub-id-type="pmid">27622770</pub-id></mixed-citation>
</ref>
<ref id="bibr19-0963689718822811">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Kritskiy</surname><given-names>O</given-names></name><name><surname>Watson</surname><given-names>LA</given-names></name><name><surname>Barker</surname><given-names>SJ</given-names></name><name><surname>Dey</surname><given-names>D</given-names></name><name><surname>Raja</surname><given-names>WK</given-names></name><name><surname>Lin</surname><given-names>YT</given-names></name><name><surname>Ko</surname><given-names>T</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Penney</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>MC</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of
Frontotemporal Dementia</article-title>. <source/>J Neurosci.
<year>2017</year>;<volume>37</volume>(<issue>41</issue>):<fpage>9917</fpage>–<lpage>9924</lpage>.<pub-id pub-id-type="pmid">28912154</pub-id></mixed-citation>
</ref>
<ref id="bibr20-0963689718822811">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bershteyn</surname><given-names>M</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Di Lullo</surname><given-names>E</given-names></name><name><surname>Nene</surname><given-names>A</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group>
<article-title>Human iPSC-derived cerebral organoids model cellular
features of lissencephaly and reveal prolonged mitosis of outer radial
glia</article-title>. <source/>Cell Stem Cell.
<year>2017</year>;<volume>20</volume>(<issue>4</issue>):<fpage>435</fpage>–<lpage>449</lpage>.e4.<pub-id pub-id-type="pmid">28111201</pub-id></mixed-citation>
</ref>
<ref id="bibr21-0963689718822811">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mora-Bermúdez</surname><given-names>F</given-names></name><name><surname>Badsha</surname><given-names>F</given-names></name><name><surname>Kanton</surname><given-names>S</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Vernot</surname><given-names>B</given-names></name><name><surname>Köhler</surname><given-names>K</given-names></name><name><surname>Voigt</surname><given-names>B</given-names></name><name><surname>Okita</surname><given-names>K</given-names></name><name><surname>Maricic</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Lachmann</surname><given-names>R</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Differences and similarities between human and chimpanzee neural
progenitors during cerebral cortex development</article-title>. <source/>Elife.
<year>2016</year>;<volume>5</volume>:<fpage>e18683</fpage>.<pub-id pub-id-type="pmid">27669147</pub-id></mixed-citation>
</ref>
<ref id="bibr22-0963689718822811">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoon</surname><given-names>KJ</given-names></name><name><surname>Ringeling</surname><given-names>FR</given-names></name><name><surname>Vissers</surname><given-names>C</given-names></name><name><surname>Jacob</surname><given-names>F</given-names></name><name><surname>Pokrass</surname><given-names>M</given-names></name><name><surname>Jimenez-Cyrus</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>NS</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Temporal control of mammalian cortical neurogenesis by m6A
methylation</article-title>. <source/>Cell.
<year>2017</year>;<volume>171</volume>(<issue>4</issue>):<fpage>877</fpage>–<lpage>889</lpage>.e17.<pub-id pub-id-type="pmid">28965759</pub-id></mixed-citation>
</ref>
<ref id="bibr23-0963689718822811">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Mokhtari</surname><given-names>R</given-names></name><name><surname>Pedrosa</surname><given-names>E</given-names></name><name><surname>Kirschenbaum</surname><given-names>M</given-names></name><name><surname>Bayrak</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Lachman</surname><given-names>HM</given-names></name></person-group>
<article-title>CRISPR/Cas9-mediated heterozygous knockout of the autism
gene CHD8 and characterization of its transcriptional networks in cerebral organoids
derived from iPS cells</article-title>. <source/>Mol Autism.
<year>2017</year>;<volume>8</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">28321286</pub-id></mixed-citation>
</ref>
<ref id="bibr24-0963689718822811">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Missler</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Biederer</surname><given-names>T</given-names></name></person-group>
<article-title>Synaptic cell adhesion</article-title>. <source/>Cold
Spring Harb Perspect Biol.
<year>2012</year>;<volume>4</volume>(<issue>4</issue>):<fpage>a005694</fpage>.<pub-id pub-id-type="pmid">22278667</pub-id></mixed-citation>
</ref>
<ref id="bibr25-0963689718822811">
<label>25</label>
<mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Pickel</surname><given-names>V</given-names></name><name><surname>Segal</surname><given-names>M</given-names></name></person-group>, (eds.). <article-title>The Synapse- Structure and
Function</article-title>. <publisher-loc>New York</publisher-loc>:
<publisher-name>Academic Press</publisher-name>; <year>2014</year>.</mixed-citation>
</ref>
<ref id="bibr26-0963689718822811">
<label>26</label>
<mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group>, (eds.). <article-title>Structural and Functional Organization of the
Synapse</article-title>. <publisher-loc>New York</publisher-loc>:
<publisher-name>Springer US</publisher-name>; <year>2008</year>.</mixed-citation>
</ref>
<ref id="bibr27-0963689718822811">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group>
<article-title>Postnatal neurodevelopmental disorders: meeting at the
synapse?</article-title>
<source/>Science.
<year>2003</year>;<volume>302</volume>(<issue>5646</issue>):<fpage>826</fpage>–<lpage>830</lpage>.<pub-id pub-id-type="pmid">14593168</pub-id></mixed-citation>
</ref>
<ref id="bibr28-0963689718822811">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>HY</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<article-title>Synaptic dysfunction in neurodevelopmental disorders
associated with autism and intellectual disabilities</article-title>. <source/>Cold
Spring Harb Perspect Biol.
<year>2012</year>;<volume>4</volume>(<issue>3</issue>):<fpage>4</fpage>.</mixed-citation>
</ref>
<ref id="bibr29-0963689718822811">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K</given-names></name><name><surname>Blundell</surname><given-names>J</given-names></name><name><surname>Etherton</surname><given-names>MR</given-names></name><name><surname>Hammer</surname><given-names>RE</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group>
<article-title>A neuroligin-3 mutation implicated in autism increases
inhibitory synaptic transmission in mice</article-title>. <source/>Science.
<year>2007</year>;<volume>318</volume>(<issue>5847</issue>):<fpage>71</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
</ref>
<ref id="bibr30-0963689718822811">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M</given-names></name><name><surname>Földy</surname><given-names>C</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Tabuchi</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Shamloo</surname><given-names>M</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group>
<article-title>Autism-linked neuroligin-3 R451C mutation differentially
alters hippocampal and cortical synaptic function</article-title>. <source/>Proc Natl
Acad Sci U S A.
<year>2011</year>;<volume>108</volume>(<issue>33</issue>):<fpage>13764</fpage>–<lpage>13769</lpage>.<pub-id pub-id-type="pmid">21808020</pub-id></mixed-citation>
</ref>
<ref id="bibr31-0963689718822811">
<label>31</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Aminoff</surname><given-names>MJ.</given-names></name></person-group>
<chapter-title>Electrophysiology</chapter-title> In: <source/>Textbook of Clinical
Neurology (<edition>3rd</edition>).
<publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Saunders</publisher-name>;
<year>2007</year>.</mixed-citation>
</ref>
<ref id="bibr32-0963689718822811">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hofer</surname><given-names>SB</given-names></name><name><surname>Ko</surname><given-names>H</given-names></name><name><surname>Pichler</surname><given-names>B</given-names></name><name><surname>Vogelstein</surname><given-names>J</given-names></name><name><surname>Ros</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Lein</surname><given-names>E</given-names></name><name><surname>Lesica</surname><given-names>NA</given-names></name><name><surname>Mrsic-Flogel</surname><given-names>TD</given-names></name></person-group>
<article-title>Differential connectivity and response dynamics of
excitatory and inhibitory neurons in visual cortex</article-title>. <source/>Nat
Neurosci.
<year>2011</year>;<volume>14</volume>(<issue>8</issue>):<fpage>1045</fpage>–<lpage>1052</lpage>.<pub-id pub-id-type="pmid">21765421</pub-id></mixed-citation>
</ref>
<ref id="bibr33-0963689718822811">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yakoub</surname><given-names>AM</given-names></name><name><surname>Sadek</surname><given-names>M</given-names></name></person-group>
<article-title>Development and characterization of human cerebral
organoids: an optimized approach</article-title>. <source/>Cell Transplant.
<year>2018</year>;<volume>27</volume>(<issue>3</issue>):<fpage>393</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">29749250</pub-id></mixed-citation>
</ref>
<ref id="bibr34-0963689718822811">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>S</given-names></name></person-group>
<article-title>Toward a molecular catalogue of synapses</article-title>.
<source/>Brain Res Rev.
<year>2007</year>;<volume>55</volume>(<issue>2</issue>):<fpage>445</fpage>–<lpage>449</lpage>.<pub-id pub-id-type="pmid">17572504</pub-id></mixed-citation>
</ref>
<ref id="bibr35-0963689718822811">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O’Rourke</surname><given-names>N</given-names></name><name><surname>Weiler</surname><given-names>N</given-names></name><name><surname>Micheva</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>SJ</given-names></name></person-group>
<article-title>Deep molecular diversity of mammalian synapses: why it
matters and how to measure it</article-title>. <source/>Nat Rev Neurosci.
<year>2012</year>;<volume>13</volume>(<issue>6</issue>):<fpage>365</fpage>–<lpage>379</lpage>.<pub-id pub-id-type="pmid">22573027</pub-id></mixed-citation>
</ref>
<ref id="bibr36-0963689718822811">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Hoogenraad</surname><given-names>C</given-names></name></person-group>
<article-title>The postsynaptic architecture of excitatory synapses: a
more quantitative view</article-title>. <source/>Annu Rev Biochem.
<year>2007</year>;<volume>76</volume>:<fpage>823</fpage>–<lpage>847</lpage>.<pub-id pub-id-type="pmid">17243894</pub-id></mixed-citation>
</ref>
<ref id="bibr37-0963689718822811">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sassoè-Pognetto</surname><given-names>M</given-names></name><name><surname>Frola</surname><given-names>E</given-names></name><name><surname>Pregno</surname><given-names>G</given-names></name><name><surname>Briatore</surname><given-names>F</given-names></name><name><surname>Patrizi</surname><given-names>A</given-names></name></person-group>
<article-title>Understanding the molecular diversity of gabaergic
synapses</article-title>. <source/>Front Cell Neurosci.
<year>2011</year>;<volume>5</volume>:<fpage>4</fpage>.<pub-id pub-id-type="pmid">21713106</pub-id></mixed-citation>
</ref>
<ref id="bibr38-0963689718822811">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Cameron</surname><given-names>R</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group>
<article-title>Synapsin I (protein I), a nerve terminal-specific
phosphoprotein. I. Its general distribution in synapses of the central and peripheral
nervous system demonstrated by immunofluorescence in frozen and plastic
sections</article-title>. <source/>J Cell Biol.
<year>1983</year>;<volume>96</volume>(<issue>5</issue>):<fpage>1337</fpage>–<lpage>1354</lpage>.<pub-id pub-id-type="pmid">6404910</pub-id></mixed-citation>
</ref>
<ref id="bibr39-0963689718822811">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hilfiker</surname><given-names>S</given-names></name><name><surname>Pieribone</surname><given-names>VA</given-names></name><name><surname>Czernik</surname><given-names>AJ</given-names></name><name><surname>Kao</surname><given-names>HT</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group>
<article-title>Synapsins as regulators of neurotransmitter
release</article-title>. <source/>Philos Trans R Soc Lond B Biol Sci.
<year>1999</year>;<volume>354</volume>(<issue>1381</issue>):<fpage>269</fpage>–<lpage>279</lpage>.<pub-id pub-id-type="pmid">10212475</pub-id></mixed-citation>
</ref>
<ref id="bibr40-0963689718822811">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Micheva</surname><given-names>KD</given-names></name><name><surname>Busse</surname><given-names>B</given-names></name><name><surname>Weiler</surname><given-names>NC</given-names></name><name><surname>O’Rourke</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>SJ</given-names></name></person-group>
<article-title>Single-synapse analysis of a diverse synapse population:
proteomic imaging methods and markers</article-title>. <source/>Neuron.
<year>2010</year>;<volume>68</volume>(<issue>4</issue>):<fpage>639</fpage>–<lpage>653</lpage>.<pub-id pub-id-type="pmid">21092855</pub-id></mixed-citation>
</ref>
<ref id="bibr41-0963689718822811">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group>
<article-title>NMDA Receptor-dependent long-term potentiation and
long-term depression (LTP/LTD)</article-title>. <source/>Cold Spring Harb Perspect
Biol.
<year>2012</year>;<volume>4</volume>(<issue>6</issue>):<fpage>a005710</fpage>.<pub-id pub-id-type="pmid">22510460</pub-id></mixed-citation>
</ref>
<ref id="bibr42-0963689718822811">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Tsien</surname><given-names>JZ</given-names></name></person-group>
<article-title>Memory and the NMDA receptors</article-title>. <source/>N
Engl J Med.
<year>2009</year>;<volume>361</volume>(<issue>3</issue>):<fpage>302</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">19605837</pub-id></mixed-citation>
</ref>
<ref id="bibr43-0963689718822811">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Popescu</surname><given-names>A</given-names></name><name><surname>Poo</surname><given-names>MM</given-names></name></person-group>
<article-title>Essential role of presynaptic NMDA receptors in
activity-dependent BDNF secretion and corticostriatal LTP</article-title>.
<source/>Neuron.
<year>2014</year>;<volume>84</volume>(<issue>5</issue>):<fpage>1009</fpage>–<lpage>1022</lpage>.<pub-id pub-id-type="pmid">25467984</pub-id></mixed-citation>
</ref>
<ref id="bibr44-0963689718822811">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Charton</surname><given-names>JP</given-names></name><name><surname>Herkert</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>CM</given-names></name><name><surname>Schröder</surname><given-names>H</given-names></name></person-group>
<article-title>Cellular and subcellular localization of the 2B-subunit of
the NMDA receptor in the adult rat telencephalon</article-title>. <source/>Brain
Res.
<year>1999</year>;<volume>816</volume>(<issue>2</issue>):<fpage>609</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">9878886</pub-id></mixed-citation>
</ref>
<ref id="bibr45-0963689718822811">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brasier</surname><given-names>DJ</given-names></name><name><surname>Feldman</surname><given-names>DE</given-names></name></person-group>
<article-title>Synapse-specific expression of functional presynaptic NMDA
receptors in rat somatosensory cortex</article-title>. <source/>J Neurosci.
<year>2008</year>;<volume>28</volume>(<issue>9</issue>):<fpage>2199</fpage>–<lpage>2211</lpage>.<pub-id pub-id-type="pmid">18305253</pub-id></mixed-citation>
</ref>
<ref id="bibr46-0963689718822811">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aoki</surname><given-names>C</given-names></name><name><surname>Venkatesan</surname><given-names>C</given-names></name><name><surname>Go</surname><given-names>CG</given-names></name><name><surname>Mong</surname><given-names>JA</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name></person-group>
<article-title>Cellular and subcellular localization of NMDA-R1 subunit
immunoreactivity in the visual cortex of adult and neonatal rats</article-title>.
<source/>J Neurosci.
<year>1994</year>;<volume>14</volume>(<issue>9</issue>):<fpage>5202</fpage>–<lpage>5222</lpage>.<pub-id pub-id-type="pmid">8083731</pub-id></mixed-citation>
</ref>
<ref id="bibr47-0963689718822811">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dingledine</surname><given-names>R</given-names></name><name><surname>Borges</surname><given-names>K</given-names></name><name><surname>Bowie</surname><given-names>D</given-names></name><name><surname>Traynelis</surname><given-names>SF</given-names></name></person-group>
<article-title>The glutamate receptor ion channels</article-title>.
<source/>Pharmacol Rev.
<year>1999</year>;<volume>51</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">10049997</pub-id></mixed-citation>
</ref>
<ref id="bibr48-0963689718822811">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group>
<article-title>Synaptic plasticity: LTP and LTD</article-title>.
<source/>Curr Opin Neurobiol.
<year>1994</year>;<volume>4</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>399</lpage>.<pub-id pub-id-type="pmid">7919934</pub-id></mixed-citation>
</ref>
<ref id="bibr49-0963689718822811">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Green</surname><given-names>MV</given-names></name><name><surname>Thayer</surname><given-names>SA</given-names></name></person-group>
<article-title>NMDARs adapt to neurotoxic HIV protein tat downstream of a
GluN2A-ubiquitin ligase signaling pathway</article-title>. <source/>J Neurosci.
<year>2016</year>;<volume>36</volume>(<issue>50</issue>):<fpage>12640</fpage>–<lpage>12649</lpage>.<pub-id pub-id-type="pmid">27810933</pub-id></mixed-citation>
</ref>
<ref id="bibr50-0963689718822811">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mi</surname><given-names>R</given-names></name><name><surname>Sia</surname><given-names>GM</given-names></name><name><surname>Rosen</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Moghekar</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>JL</given-names></name><name><surname>McEnery</surname><given-names>M</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>O’Brien</surname><given-names>RJ</given-names></name></person-group>
<article-title>AMPA receptor-dependent clustering of synaptic NMDA
receptors is mediated by Stargazin and NR2A/B in spinal neurons and hippocampal
interneurons</article-title>. <source/>Neuron.
<year>2004</year>;<volume>44</volume>(<issue>2</issue>):<fpage>335</fpage>–<lpage>349</lpage>.<pub-id pub-id-type="pmid">15473971</pub-id></mixed-citation>
</ref>
<ref id="bibr51-0963689718822811">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>JL</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Gao</surname><given-names>WJ</given-names></name><name><surname>Huang</surname><given-names>YQ</given-names></name></person-group>
<article-title>Dopamine D1 receptor-mediated NMDA receptor insertion
depends on Fyn but not Src kinase pathway in prefrontal cortical
neurons</article-title>. <source/>Mol Brain.
<year>2010</year>;<volume>3</volume>:<fpage>20</fpage>.<pub-id pub-id-type="pmid">20569495</pub-id></mixed-citation>
</ref>
<ref id="bibr52-0963689718822811">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hughes</surname><given-names>EG</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Gleichman</surname><given-names>AJ</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tsou</surname><given-names>R</given-names></name><name><surname>Parsons</surname><given-names>TD</given-names></name><name><surname>Lynch</surname><given-names>DR</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Balice-Gordon</surname><given-names>RJ</given-names></name></person-group>
<article-title>Cellular and synaptic mechanisms of anti-NMDA receptor
encephalitis</article-title>. <source/>J Neurosci.
<year>2010</year>;<volume>30</volume>(<issue>17</issue>):<fpage>5866</fpage>–<lpage>5875</lpage>.<pub-id pub-id-type="pmid">20427647</pub-id></mixed-citation>
</ref>
<ref id="bibr53-0963689718822811">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>JS</given-names></name><name><surname>Rooyakkers</surname><given-names>A</given-names></name><name><surname>She</surname><given-names>K</given-names></name><name><surname>Ribeiro</surname><given-names>L</given-names></name><name><surname>Carvalho</surname><given-names>AL</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group>
<article-title>Activity and protein kinase C regulate synaptic
accumulation of N-methyl-D-aspartate (NMDA) receptors independently of GluN1 splice
variant</article-title>. <source/>J Biol Chem.
<year>2011</year>;<volume>286</volume>(<issue>32</issue>):<fpage>28331</fpage>–<lpage>28342</lpage>.<pub-id pub-id-type="pmid">21676872</pub-id></mixed-citation>
</ref>
<ref id="bibr54-0963689718822811">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vastagh</surname><given-names>C</given-names></name><name><surname>Gardoni</surname><given-names>F</given-names></name><name><surname>Bagetta</surname><given-names>V</given-names></name><name><surname>Stanic</surname><given-names>J</given-names></name><name><surname>Zianni</surname><given-names>E</given-names></name><name><surname>Giampà</surname><given-names>C</given-names></name><name><surname>Picconi</surname><given-names>B</given-names></name><name><surname>Calabresi</surname><given-names>P</given-names></name><name><surname>Di Luca</surname><given-names>M</given-names></name></person-group>
<article-title>N-methyl-D-aspartate (NMDA) receptor composition modulates
dendritic spine morphology in striatal medium spiny neurons</article-title>. <source/>J
Biol Chem.
<year>2012</year>;<volume>287</volume>(<issue>22</issue>):<fpage>18103</fpage>–<lpage>18114</lpage>.<pub-id pub-id-type="pmid">22493505</pub-id></mixed-citation>
</ref>
<ref id="bibr55-0963689718822811">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pickard</surname><given-names>L</given-names></name><name><surname>Noël</surname><given-names>J</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Molnar</surname><given-names>E</given-names></name></person-group>
<article-title>Developmental changes in synaptic AMPA and NMDA receptor
distribution and AMPA receptor subunit composition in living hippocampal
neurons</article-title>. <source/>J Neurosci.
<year>2000</year>;<volume>20</volume>(<issue>21</issue>):<fpage>7922</fpage>–<lpage>7931</lpage>.<pub-id pub-id-type="pmid">11050112</pub-id></mixed-citation>
</ref>
<ref id="bibr56-0963689718822811">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Hsu</surname><given-names>FC</given-names></name><name><surname>Baumann</surname><given-names>BH</given-names></name><name><surname>Coulter</surname><given-names>DA</given-names></name><name><surname>Lynch</surname><given-names>DR</given-names></name></person-group>
<article-title>Cortical synaptic NMDA receptor deficits in α7 nicotinic
acetylcholine receptor gene deletion models: implications for neuropsychiatric
diseases</article-title>. <source/>Neurobiol Dis.
<year>2014</year>;<volume>63</volume>:<fpage>129</fpage>–<lpage>140</lpage>.<pub-id pub-id-type="pmid">24326163</pub-id></mixed-citation>
</ref>
<ref id="bibr57-0963689718822811">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoey</surname><given-names>SE</given-names></name><name><surname>Williams</surname><given-names>RJ</given-names></name><name><surname>Perkinton</surname><given-names>MS</given-names></name></person-group>
<article-title>Synaptic NMDA receptor activation stimulates
alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta
production</article-title>. <source/>J Neurosci.
<year>2009</year>;<volume>29</volume>(<issue>14</issue>):<fpage>4442</fpage>–<lpage>4460</lpage>.<pub-id pub-id-type="pmid">19357271</pub-id></mixed-citation>
</ref>
<ref id="bibr58-0963689718822811">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tomita</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Kawasaki</surname><given-names>Y</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name></person-group>
<article-title>Functional studies and distribution define a family of
transmembrane AMPA receptor regulatory proteins</article-title>. <source/>J Cell
Biol.
<year>2003</year>;<volume>161</volume>(<issue>4</issue>):<fpage>805</fpage>–<lpage>816</lpage>.<pub-id pub-id-type="pmid">12771129</pub-id></mixed-citation>
</ref>
<ref id="bibr59-0963689718822811">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pérez-Otaño</surname><given-names>I</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group>
<article-title>Homeostatic plasticity and NMDA receptor
trafficking</article-title>. <source/>Trends Neurosci.
<year>2005</year>;<volume>28</volume>(<issue>5</issue>):<fpage>229</fpage>–<lpage>238</lpage>.<pub-id pub-id-type="pmid">15866197</pub-id></mixed-citation>
</ref>
<ref id="bibr60-0963689718822811">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paoletti</surname><given-names>P</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group>
<article-title>NMDA receptor subunit diversity: impact on receptor
properties, synaptic plasticity and disease</article-title>. <source/>Nat Rev
Neurosci.
<year>2013</year>;<volume>14</volume>(<issue>6</issue>):<fpage>383</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">23686171</pub-id></mixed-citation>
</ref>
<ref id="bibr61-0963689718822811">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>EG</given-names></name></person-group>
<article-title>Electron microscopy of excitatory and inhibitory synapses:
a brief review</article-title>. <source/>Prog Brain Res.
<year>1969</year>;<volume>31</volume>:<fpage>141</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">4899407</pub-id></mixed-citation>
</ref>
<ref id="bibr62-0963689718822811">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name></person-group>
<article-title>Ultrastructure of synapses in the mammalian
brain</article-title>. <source/>Cold Spring Harb Perspect Biol.
<year>2012</year>;<volume>4</volume>(<issue>5</issue>):<fpage>a005587</fpage>.<pub-id pub-id-type="pmid">22357909</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>